S&P 500 Ebbs But Holds On to Third Week Of Gains
Plus: Shares in several major banks fall after federal regulators raise concerns about their wind-down plans. Shares in Sarepta Therapeutics jump after its new muscular dystrophy gene therapy receives approval. And Nikola\u2019s stock rises after the embattled EV maker\u2019s board approves a reverse stock split. Danny Lewis hosts.\n\n\n\nSign up for the WSJ's free What's News newsletter.\n\n\n\nLearn more about your ad choices. Visit megaphone.fm/adchoices